DoW Rare Cancers Resource and Community Development Award

The DoW Rare Cancers Resource and Community Development Award supports the development of research resources and clinical or preclinical datasets that will advance the field of rare cancers research and ultimately improve outcomes for individuals with rare cancers. The award focuses on addressing major gaps in patient care for rare cancers, including the lack of research and clinical resources, communication and dissemination strategies, infrastructure for sharing data and other resources, and therapeutics and mechanistic research to inform treatment development. The award requires the development of research platforms that can share resources and knowledge pertaining to available preclinical or clinical research models, molecular pathways, and therapeutic approaches. Key elements of the award include the involvement of Patient Advocates, the development of novel methods and systems for collection, sharing, and analysis of data or biospecimens, and the sustainability of the resource in the future. • The award has a maximum period of performance of 4 years and a total cost cap of $1.12M. • The award is open to extramural and intramural U.S. Department of War (DOW) organizations, including foreign and domestic organizations, for-profit and nonprofit organizations, and public or private entities. • The award requires a two-step application process, with a pre-application submission followed by a full application submission. • The award has specific requirements for the involvement of Patient Advocates, the development of research platforms, and the sustainability of the resource. • The award has a focus on rare cancers research and requires applicants to address one or more of the following focus areas: Platform Development, Artificial Intelligence (AI) and Machine Learning (ML) Model.